Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sarcomatous Mesothelioma”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Study completedNCT00107432
What this trial is testing

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

Who this might be right for
Epithelial MesotheliomaRecurrent Malignant MesotheliomaSarcomatous Mesothelioma+5 more
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00227630
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 59
Testing effectiveness (Phase 2)Study completedNCT00054002
What this trial is testing

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Roswell Park Cancer Institute 12
Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00365053
What this trial is testing

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 13
Not applicableEnded earlyNCT00898547
What this trial is testing

Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)WithdrawnNCT01105390
What this trial is testing

AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT01064648
What this trial is testing

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Epithelioid MesotheliomaPleural Malignant MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 117
Testing effectiveness (Phase 2)Study completedNCT00039182
What this trial is testing

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00027703
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 106
Testing effectiveness (Phase 2)Ended earlyNCT01861301
What this trial is testing

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Epithelioid MesotheliomaRecurrent Malignant MesotheliomaSarcomatoid Mesothelioma+3 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Looking for participantsNCT05647265
What this trial is testing

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Who this might be right for
Pleural Biphasic MesotheliomaPleural Sarcomatoid Mesothelioma
Alliance for Clinical Trials in Oncology 26
Testing effectiveness (Phase 2)Study completedNCT00309946
What this trial is testing

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaLocalized Malignant Mesothelioma+2 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Study completedNCT00509041
What this trial is testing

Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Testing effectiveness (Phase 2)Study completedNCT00243074
What this trial is testing

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00025207
What this trial is testing

Gefitinib in Treating Patients With Malignant Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00053885
What this trial is testing

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Study completedNCT00003723
What this trial is testing

S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 57
Testing effectiveness (Phase 2)Study completedNCT00004183
What this trial is testing

Capecitabine in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 27
Load More Results